Artelon Inc.

About Artelon Inc.

Artelon focuses on dynamic innovations for tendon and ligament injuries, aiming to enhance the strength of repaired and healing tissues while promoting stable motion and integrated regeneration. Their mission is to get patients back to activity through innovative stability solutions.

Products & Services

FLEXBAND:A product designed to enhance the strength of repaired and healing tissue, mimicking nature's strength preferences for stable motion. It features elastic properties to maintain soft tissue tension during active motion without stiffness, and integrates into regenerating tissue over 4 to 6 years.

Specialties

Tendon and Ligament Injury Solutions Stability Innovations Integrated Tissue Regeneration Ankle Instability Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 20000000 MR: - FA: approximately $20 million FAN: 20000000	D: 2023-05-24 FD: 2023-05-24	1 investors

Series B Latest

2023-05-24

$20.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lars Peterson

Orthopedic Surgeon, MD/PhD

D

Davis

Football Player

B

Brooklyn

Collegiate Soccer Player

C

Cody

J

Jesus

View 2 more team members with Pro

Unlock Full Team Directory

Recent News

Artelon Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised